These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8360659)

  • 1. Parkinson's Disease Brain Bank in Paris: an evolutive bank responding to the exigencies of new neurochemical methodologies.
    Javoy-Agid F
    J Neural Transm Suppl; 1993; 39():185-92. PubMed ID: 8360659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brain bank in a neuropathology laboratory (with some emphasis on diagnostic criteria).
    Duyckaerts C; Sazdovitch V; Seilhean D; Delaère P; Hauw JJ
    J Neural Transm Suppl; 1993; 39():107-18. PubMed ID: 8360651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain banks and research in neurochemistry.
    Mahy N
    J Neural Transm Suppl; 1993; 39():119-26. PubMed ID: 8360652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neuro-specimen banking 1961-1992. The National Neurological Research Specimen Bank (a donor program of pre- and post-mortem tissues and cerebrospinal fluid/blood; and a collection of cryopreserved human neurological specimens for neuroscientists).
    Tourtellotte WW; Rosario IP; Conrad A; Syndulko K
    J Neural Transm Suppl; 1993; 39():5-15. PubMed ID: 8360665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's Disease Society Brain Bank, London: overview and research.
    Daniel SE; Lees AJ
    J Neural Transm Suppl; 1993; 39():165-72. PubMed ID: 8360656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: potential targets for the development of new therapeutic agents.
    Ward RJ; Lallemand F; de Witte P; Dexter DT
    Prog Neurobiol; 2008 Jun; 85(2):135-47. PubMed ID: 18482793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease--a comparative review.
    Gsell W; Strein I; Krause U; Riederer P
    J Neural Transm Suppl; 1997; 51():145-59. PubMed ID: 9470135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of data in tissue banking: the Ariane database software developed by the Assistance Publique-Hôpitaux de Paris Tissue Bank.
    Gerota J; Colin C; Dupont M; Eugene M; Gouezo R; Marchix T; Fagot M; Benhunan M
    Transplant Proc; 1996 Feb; 28(1):246. PubMed ID: 8644204
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain banking for immunocytochemistry and autoradiography.
    Eymin C; Jordan D; Saint-Pierre G; Kopp N
    J Neural Transm Suppl; 1993; 39():127-34. PubMed ID: 8360653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
    Calon F; Dridi M; Hornykiewicz O; Bédard PJ; Rajput AH; Di Paolo T
    Brain; 2004 May; 127(Pt 5):1075-84. PubMed ID: 15033896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.
    Halliday GM; McCann H
    Exp Neurol; 2008 Jan; 209(1):12-21. PubMed ID: 17706644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical pathology and the etiology of Parkinson's disease: basic facts and hypothetical possibilities.
    Hornykiewicz O
    Mt Sinai J Med; 1988 Jan; 55(1):11-20. PubMed ID: 3279301
    [No Abstract]   [Full Text] [Related]  

  • 13. How to run a brain bank. A report from the Austro-German brain bank.
    Gsell W; Lange KW; Pfeuffer R; Heckers S; Heinsen H; Senitz D; Jellinger K; Ransmayr G; Wichart I; Vock R
    J Neural Transm Suppl; 1993; 39():31-70. PubMed ID: 8360664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical aspects to be considered in brain banking.
    Cruz-Sánchez FF; Mordini E; Ravid R
    Ann Ist Super Sanita; 1997; 33(4):477-82. PubMed ID: 9616957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data protection in biomaterial banks for Parkinson's disease research: the model of GEPARD (Gene Bank Parkinson's Disease Germany).
    Eggert K; Wüllner U; Antony G; Gasser T; Janetzky B; Klein C; Schöls L; Oertel W
    Mov Disord; 2007 Apr; 22(5):611-8. PubMed ID: 17230444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical fundamentals of Parkinson's disease.
    Riederer P; Rausch WD; Schmidt B; Kruzik P; Konradi C; Sofić E; Danielczyk W; Fischer M; Ogris E
    Mt Sinai J Med; 1988 Jan; 55(1):21-8. PubMed ID: 3279302
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's disease. Signs of disease in fetal transplants.
    Miller G
    Science; 2008 Apr; 320(5873):167. PubMed ID: 18403684
    [No Abstract]   [Full Text] [Related]  

  • 18. How to run a "brain bank"? Clinical and institutional requirements for "brain banking".
    Jendroska K; Patt S; Jänisch W; Cervos-Navarro J; Poewe W
    J Neural Transm Suppl; 1993; 39():71-5. PubMed ID: 8360666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The collection and processing of human brain tissue for research.
    Waldvogel HJ; Bullock JY; Synek BJ; Curtis MA; van Roon-Mom WM; Faull RL
    Cell Tissue Bank; 2008 Sep; 9(3):169-79. PubMed ID: 18357514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research resource network and Parkinson disease brain bank donor registration program in Japan].
    Arima K
    Brain Nerve; 2010 Oct; 62(10):1025-34. PubMed ID: 20940501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.